Microcap Ledger 60 Degrees Pharmaceuticals, Inc. $SXTP
Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.
This page is still filling in. We publish more sections as filings are processed.
Snapshot
- Exchange
- Nasdaq Capital Market
- Sector
- Pharmaceutical Preparations
- Headquarters
- Washington, DC
- Fiscal year end
- December 31
- Shares outstanding
- 3,516,988 [10-Q 2026-08-14]
Financial health
| Period | Revenue | Net income | Operating cash flow | Cash | Filing |
|---|---|---|---|---|---|
| 6 months to Jun 2026 | $370.0K | −$4.35M | −$4.97M | $1.02M | [10-Q 2026-08-14] |
| FY ended Dec 2025 | $1.01M | −$7.37M | −$6.85M | $1.51M | [10-K 2026-03-30] |
| FY ended Dec 2024 | $607.6K | −$7.95M | −$5.65M | $1.66M | [10-K 2026-03-30] |
- Quarterly cash burn
- −$2.49M
- Cash runway Estimate
- ~1.2 months
Capital structure and dilution
| Date | Shares outstanding | Filing |
|---|---|---|
| 2024-11-14 | 2,297,465 | [10-Q 2024-11-14] |
| 2025-03-27 | 1,472,891 | [10-K 2025-03-27] |
| 2025-05-15 | 1,472,891 | [10-Q 2025-05-15] |
| 2025-08-13 | 4,104,469 | [10-Q 2025-08-13] |
| 2025-11-13 | 4,230,448 | [10-Q 2025-11-13] |
| 2026-03-30 | 2,636,788 | [10-K 2026-03-30] |
| 2026-05-15 | 2,659,288 | [10-Q 2026-05-15] |
| 2026-08-14 | 3,516,988 | [10-Q 2026-08-14] |
- Shelf registration
- S-3 filed 2026-08-14; declared effective 2026-08-25 [S-3 2026-08-14]
Listing status
Current status: 1 Form 8-K Item 3.01 filing(s) in the last 24 months, most recent 2026-01-23. Item 3.01 covers delisting notices, failures to meet a listing rule and listing transfers; read the filing for which one.
| Date | Event | Details | Deadline | Filing |
|---|---|---|---|---|
| 2026-01-23 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2026-01-23] |
Who owns it
| Date | Insider | Type | Shares | Price | Filing |
|---|---|---|---|---|---|
| 2026-06-12 | Dow Geoffrey S | buy | 7,350 | $1.38 | [4 2026-06-15] |
| 2025-12-15 | Dow Geoffrey S | buy | 9,670 | $0.80 | [4 2025-12-16] |
| 2025-12-11 | Dow Geoffrey S | buy | 3,613 | $0.92 | [4 2025-12-12] |
| 2025-12-10 | Dow Geoffrey S | buy | 9,350 | $0.95 | [4 2025-12-12] |
Catalysts and calendar
| Date | Type | Title |
|---|---|---|
| 2026-10-06 | 8-K | Regulation FD disclosure; Other events |
| 2026-09-14 | 8-K | Other events |
| 2026-09-08 | 8-K | Regulation FD disclosure |
| 2026-08-14 | S-3 | Registration statement |
| 2026-08-14 | 10-Q | Quarterly report |
| 2026-08-06 | 8-K | Shareholder vote results |
| 2026-08-05 | 13G | Beneficial ownership report (5%+ holder) |
| 2026-08-04 | 8-K | Material agreement entered; Unregistered sale of equity; Other events |
| 2026-07-29 | 13G | Beneficial ownership report (5%+ holder) |
| 2026-07-20 | 8-K | Regulation FD disclosure |
| 2026-07-09 | 8-K | Other events |
| 2026-07-02 | DEF 14A | Proxy statement |
Alerts for $SXTP
Email me when 60 Degrees Pharmaceuticals, Inc. files an offering, gets a deficiency notice, or moves sharply.
Facts as of . Small caps move fast; check the latest filings.